RHHBF - Viking falls after Roche's obesity drug data
2024-05-16 13:37:18 ET
More on Viking Therapeutics
- What Makes Viking Therapeutics An Attractive Takeover Target Or Big Pharma Partner
- Viking Therapeutics: The Metabolic Masterpiece Primed To Be Acquired
- Viking Therapeutics, Inc. (VKTX) Q1 2024 Earnings Call Transcript
- Viking Therapeutics down 4% despite quarterly bottom line beat
- Viking Therapeutics gains on early data for oral weight loss therapy